Deal Ends Today·Save 35% annual plan
CNS Stimulant, Schedule IIReviewed for 2026 plan year

Does Cigna Cover Vyvanse?

The verdict

Covered on most plans

Cigna covers Vyvanse through its PBM Express Scripts — generic lisdexamfetamine is the preferred formulary option, brand Vyvanse is non-preferred as generic supply improves. A Schedule II 70 mg/day quantity limit and documented ADHD diagnosis (or adult binge-eating disorder) are required. Express Scripts allows pharmacist overrides and shortage-documented prior authorizations for brand when generic is out of stock. Verify current tier and PA requirements on the Express Scripts plan formulary.

MedicareCovered
CommercialCovered
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Cigna using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Cigna drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice
Plan types

Medicare vs. commercial coverage

Whether Cigna covers Vyvanse depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Covered

Medicare Part D (Cigna/Express Scripts Part D plans): generic lisdexamfetamine is covered and generally preferred; brand Vyvanse may require prior authorization as generic supply improves. A Schedule II 70 mg/day quantity limit applies. Verify current tier on the Cigna Medicare Part D drug list; formulary positions are updated annually.

Commercial / Employer

Group & marketplace plans

Covered

Commercial/Employer: generic lisdexamfetamine preferred at a low tier via Express Scripts; brand Vyvanse non-preferred. A 70 mg/day quantity limit and ADHD-diagnosis (or adult binge-eating disorder) requirement apply. ACA/Individual: generic preferred with QL; brand non-preferred. Medicaid (where Cigna operates Medicaid managed care): generic covered per state PDL with PA and QL. During 2024, Express Scripts plans temporarily added brand Vyvanse back due to generic supply constraints; those add-backs are now being reversed. Pharmacist override or shortage-documented PA available when generic unavailable. Verify on your Express Scripts plan formulary.

Prior authorization

The 5 boxes you must tick to get approved

Commercial plans that will consider Vyvanse require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 5

Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Vyvanse actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

Brand Vyvanse: approx. $400–$558/month (Takeda list price, estimate). Generic lisdexamfetamine: approx. $200–$360/month cash, as low as approx. $60–$70 with a coupon.

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Generic lisdexamfetamine at preferred tier: lowest cost-share (plan-specific copay or coinsurance — verify on Express Scripts/Cigna formulary). Brand Vyvanse at non-preferred tier: higher cost-share; verify on plan. Medicaid: nominal ($0–$4 typical).

Typical monthly copay once prior authorization is approved.

All cost figures are estimates. Actual cost-share depends on your specific Cigna plan tier, deductible phase, and benefit design. Verify current copays on the Express Scripts/Cigna plan formulary or by calling member services.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Search the Express Scripts or Cigna formulary online

    Go to cigna.com or expressscripts.com and use the drug lookup tool with your specific Cigna plan ID. Search both 'lisdexamfetamine' (generic) and 'Vyvanse' (brand) to see the current tier, quantity limit, and PA requirements for 2026.

  2. 2

    Call Cigna member services

    Call the number on the back of your Cigna card and ask: (1) Is generic lisdexamfetamine covered at a preferred tier? (2) Is brand Vyvanse non-preferred, and what does it cost? (3) What is the quantity limit and is PA required? (4) What is the brand override process if the generic is out of stock?

  3. 3

    Have your prescriber submit the prior authorization

    Your prescriber submits PA documentation to Express Scripts including the ADHD or binge-eating disorder diagnosis, dose within the 70 mg/day QL, and — for brand Vyvanse — documented generic unavailability. Cigna's Express Scripts PA portal routes the submission electronically. Confirm the process with your prescriber's office.

If it's denied

Options if Cigna won't cover Vyvanse

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Generic lisdexamfetamine

The preferred formulary option via Express Scripts. Same active ingredient as brand Vyvanse; FDA-approved August 2023. Cash approx. $200–$360/month; as low as approx. $60–$70 with coupon. Verify pharmacy stock — intermittent shortage continues despite DEA 2026 quota increase.

Generic amphetamine/dextroamphetamine (Adderall generic)

Covered at a low formulary tier on Cigna/Express Scripts plans. Different chemical from lisdexamfetamine; not FDA-approved for binge-eating disorder. Cash approx. $17–$55/30 days. Prescriber must assess clinical appropriateness.

Generic extended-release amphetamine formulations

Various generic XR amphetamine formulations are typically low-tier on Express Scripts commercial formularies. Verify specific product coverage on the Cigna/Express Scripts drug list.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

Cigna, through Express Scripts, now prefers generic lisdexamfetamine over brand Vyvanse. Brand Vyvanse is non-preferred — it typically requires a formulary exception or shortage-documented PA. During 2024, Express Scripts temporarily added brand Vyvanse back due to generic supply constraints; those add-backs are being reversed as supply improves. If your pharmacy cannot fill the generic, ask your prescriber to document the shortage and request brand authorization through Express Scripts.

Cigna/Express Scripts applies a Schedule II quantity limit of 70 mg per day for lisdexamfetamine (generic or brand), consistent with FEP standard criteria (CVS Caremark Policy 5.60.024, eff. April 1, 2026). No automatic refills are permitted; a new Schedule II prescription is required for each fill. Verify the specific QL for your Cigna plan on the Express Scripts formulary.

Most Cigna/Express Scripts plans cover lisdexamfetamine for both ADHD and adult binge-eating disorder, consistent with FDA labeling. Prior authorization requires documentation of the BED diagnosis. Coverage may vary on Cigna Medicaid managed care plans depending on state PDL rules. Verify the binge-eating disorder PA criteria on the Express Scripts formulary or with Cigna member services.

When generic lisdexamfetamine is unavailable, Express Scripts allows pharmacist overrides for brand Vyvanse dispensing or shortage-documented prior authorization for brand coverage. To use this pathway, have your prescriber document that the generic was unavailable at local pharmacies and submit a PA citing the shortage. The DEA set the 2026 lisdexamfetamine production quota at over 51 million grams, but finished-pill supply lags the quota increase.

All three carriers prefer generic lisdexamfetamine over brand Vyvanse, but the PBM differs: Cigna uses Express Scripts, Aetna uses CVS Caremark, and UHC uses OptumRx. The generic-preferred outcome and 70 mg/day QL are consistent across the three PBMs. Aetna's FEP criteria through CVS Caremark (Policy 5.60.024) provide the most explicitly documented QL and age-edit numbers. Verify your specific Cigna plan formulary for exact tier and PA requirements.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Cigna before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.